IHME experts speak

Por su 75 aniversario, la OMS ha decidido compartir una lista de “mensajes clave” dirigidos a dos receptores: el público y los gobiernos. Rafael Lozano, profesor de IHME, comparte sus pensamientos sobre los mensajes claves.

Even mild COVID-19 cases can have major and long-lasting effects on people’s health. IHME researchers share key findings from a recent multicountry study on long COVID.

The Lancet announces a new commission to examine the broad set of threats facing the world over the rest of the century.

Researchers Emily Johnson and Joseph Dieleman share the results from a study estimating health spending in the US by state.

We developed a new method for assessing health risks that our research suggests should make it a lot easier for people to determine which health advice to follow – and which to ignore.

Dr. Chris Murray shares new research on how much certain foods increased the risk of developing a particular disease – or if they could even protect you.

The Global Burden of Disease Study (GBD) began 30 years ago with the goal of providing timely, valid, and relevant assessments of critical health outcomes. IHME director Dr. Chris Murray reflects on progress made since then, and limitations yet to overcome.

The Census Bureau must improve its data anonymization methods to protect vulnerable groups. IHME professor Abraham Flaxman explains why.

IHME professor Emmanuela Gakidou discusses the results of a study published in The Lancet on safe levels of alcohol consumption.

Although democracy alone might not be a panacea for every pandemic of an emerging infection, evidence suggests it has helped against COVID-19, especially when there is public trust.

Dr. Chris Murray talks with Here & Now's Robin Young about the IHME study of superbugs published in The Lancet and the future of antibiotic-resistant bacteria.

On this 146th episode, Dr. Chris Murray, IHME, delivers several sharp messages.

Marcia Weaver from the University of Washington joins A Health Podyssey to discuss whether we receive value for our high levels of health spending.

How to solve the predicament of Shanghai and beyond? China has now three options to deal with the pandemic, each with some pros and cons.

Aggravated by COVID-19 and a devastating port explosion, Lebanon, once one of the prominent health-care hubs in the Middle East and north African region, can hardly remain afloat.

Over the past three decades, the world has witnessed perhaps the most dramatic demographic and epidemiological transitions in China.

In a study that I published in February in the medical journal The Lancet, with colleagues from the Institute for Health Metrics and Evaluation and the Council on Foreign Relations, we fou

La revista The Lancet publicó un artículo elaborado por investigadores del Instituto de la Métrica y Evaluación para la Salud (IHME por sus siglas en inglés)  titulado “La preparación para una pandemia y COVID-19: un análisis exploratorio de las tasas de infección y mortalidad, y los factores contextuales asociados con la preparación en 177 países, del 1 de enero de 2020 al 30 de septiembre de 2021.”

Why hasn’t the pandemic hit all nations equally hard? The answer may lie in the confidence people place in their governments and each other.

IHME Director Dr. Christopher J.L. Murray explains why extraordinary social and economic disruptions from COVID-19 will end soon.

De acuerdo con las estimaciones de IHME, se registran al 31 de diciembre de 2020 1.9 millones de muertes por Covid-19 y se estima que durante 2021 se registrarán 3.6 millones de muertes más, lo que arroja un total de 5.5 millones de muertes por la pandemia en 2 años. Queda claro que los daños letales de la pandemia en el mundo fueron casi el doble en 2021 en comparación con 2020.

In the U.S., over 17,000 children have been hospitalized, over 4,000 have suffered from Multisystem Inflammatory Syndrome and more than 400 have died due to COVID-19. Vaccines — our most effective tool — aim to protect vaccinated individuals but also those who cannot be vaccinated, including children under the age of 12. This works by building a “wall” of immunized individuals around these groups — what we call herd immunity.

So far, we have failed.

IHME Director Christopher JL Murray remembers Tachi Yamada as a champion for global health.

The COVID-19 crisis is far from over; in many countries, it is getting worse. By investing in digital technologies now and publishing anonymized data online, policymakers can strengthen their response to the ongoing pandemic, and act quickly when another public-health threat appears.

With an excess of COVID-19 vaccines in high-income settings, leaders of those countries should act on their promises to send surplus doses to countries where vaccines remain scarce.